Co-diagnostics, inc. to host booth and discuss recent grant awards at aacc 2023 in anaheim, ca

Salt lake city , july 20, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is hosting a booth at the american association for clinical chemistry (aacc) annual meeting and expo held july 23-27, 2023 in anaheim, ca. co-dx will also be holding a special milestone presentation and company update to discuss recent grant activity announced earlier this month related to development of the upper respiratory (flu/covid/rsv), tuberculosis, and hpv tests on its upcoming co-dx pcr home platform.
CODX Ratings Summary
CODX Quant Ranking